Martin Shkreli 5.0 36 ideas
Investor / Podcast host
ⓘ Each mention is one idea
After 1 day
44%winrate
+0.8% avg
7W / 9L · 16/12 ideas
After 1 week
56%winrate
+2.8% avg
9W / 7L · 16/12 ideas
After 1 month
47%winrate
-0.1% avg
9W / 10L · 19/12 ideas
After 3 months
N/A
9/15 min ideas
36 total mentions ·
13 actionable
(6 long · 7 short)
· 2 watch
· 16 neutral
· 5 avoid
Win-rate includes long + short only. Short wins when price falls.
By theme
Healthcare
14 ideas
+8.9%
AI/Semi
11 ideas
-4.6%
Other
6 ideas
-7.8%
Crypto
3 ideas
+6.8%
Consumer
2 ideas
-0.7%
Top tickers (by frequency)
CAPR
5 ideas
100% W
+8.3%
QCLS
3 ideas
0% W
-10.8%
IONQ
3 ideas
50% W
+1.6%
QBTS
2 ideas
0% W
-26.5%
LLY
2 ideas
0% W
-3.3%
Best and worst 30-day returns
Price change 30 days after entry. Extreme outliers excluded.
Best calls
TAO SHORT
+12.7%
The speaker would short TAO, implying that its lack of recognition among informed participants suggests it is likely an ...
Mar 16
DAWN LONG
+1.2%
The author is reaffirming a previous long call ("The stock $DAWN is a good long idea. Probably doubles."), indicating th...
Mar 06
RGTI SHORT
-0.4%
1. THE FACT: Shkreli is shorting more quantum stocks, stating "if NVDA catches a cold, they die of marburg."
2. THE BRID...
Nov 24
Worst calls
QBTS SHORT
-26.5%
1. THE FACT: Shkreli is shorting more quantum stocks, stating "if NVDA catches a cold, they die of marburg."
2. THE BRID...
Nov 24
IONQ SHORT
-15.0%
1. THE FACT: Shkreli is shorting more quantum stocks, stating "if NVDA catches a cold, they die of marburg."
2. THE BRID...
Nov 24
QCLS LONG
-9.0%
1. THE FACT: The speaker states, "we bought a photonic/optical computing stock: $QCLS. i'm convinced that the answer to ...
Dec 03
Martin Shkreli notes that while drugmakers will likely push patients to newer molecules, generic Ozempic will remain a tough competitor in the market.
LLY
Apr 27, 17:48
Investor / Podcast host
Bullish on Novo Nordisk as existing generic Ozempic is expected to maintain dominance over new entrants, implying sustained market share.
NVO
MED
Apr 27, 17:48
Investor / Podcast host
Martin Shkreli comments that semaglutide going generic is not a big leap, implying limited market impact from the event.
NVO
Apr 27, 17:45
Investor / Podcast host
Martin Shkreli sarcastically encourages going long on SLS, implying a bearish view on the stock's prospects.
SLS
HIGH
Apr 26, 16:59
Investor / Podcast host
Short GSK because the high level of competition in the pharmaceutical industry makes it statistically improbable for GSK to exclusively develop a cure for asthma, negating a potential source of future upside.
GSK
HIGH
Apr 10, 21:47
The author alleges STRC is committing securities fraud through misleading advertising, implying the stock is overvalued and should be shorted.
STRC
HIGH
Mar 30, 20:48
The author has high conviction that the sports betting industry faces existential regulatory risk, arguing for an outright ban which would be catastrophic for the sector.
DKNG
HIGH
Mar 20, 15:12
The speaker is announcing a strategic initiative to build an optical computer for AI, implying this will be a significant long-term value driver for the company.
QCLS
HIGH
Mar 18, 14:05
Short Canopy Growth as its income statement is exceptionally poor, indicating severe fundamental weakness in the business.
CGC
MED
Mar 18, 01:37
The author is sarcastically implying that HCA Healthcare's business has low margins, suggesting a bearish view on the stock's fundamentals.
HCA
MED
Mar 17, 23:47
The author, a known pharma expert, strongly defends the legitimacy and highlights the significant late-stage (Phase 3) trial status of Eli Lilly's drug Retatrutide, implying a bullish outlook on its prospects.
LLY
MED
Mar 17, 17:22
The speaker would short TAO, implying that its lack of recognition among informed participants suggests it is likely an overhyped or insignificant asset.
TAO
MED
Mar 16, 18:49
Shorting the stock based on the speaker's conviction that the company's clinical data is fraudulent, implying the asset's value is based on false information.
CAPR
HIGH
Mar 10, 18:31
@jxnlco gpu mining of bitcoin has not been viable in a long time
BTC
Mar 07, 14:23
The speaker has a strong fundamental view that the company IONQ has no value, implying its stock price should go to zero.
IONQ
HIGH
Mar 07, 14:05